Finance

Lists
Q3 2026 earnings • released • EPS beat +14 014,11% • Revenue met 0,00%
See results
PHM:BME
Pharma Mar SA
67,50 €
-2,53%
(-1,75) 1D
30-окт., 17:36:00 GMT+1  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for PHM...
Open
68,90 €
High
69,35 €
Low
66,00 €
Mkt. cap
1,24 млд
Avg. vol.
26,90 миң
Volume
71,66 миң
Dividend
1,48%
Quarterly dividend
0,25 €
Ex-dividend date
2023-ж., 7-июн.
P/E ratio
20,54
52-wk high
105,20 €
52-wk low
64,00 €
EPS
3,29 €
Shares outstanding
18,00 млн
No. of employees
505
Open
68,90 €
High
69,35 €
Low
66,00 €
Mkt. cap
1,24 млд
Avg. vol.
26,90 миң
Volume
71,66 миң
Dividend
1,48%
Quarterly dividend
0,25 €
Ex-dividend date
2023-ж., 7-июн.
P/E ratio
20,54
52-wk high
105,20 €
52-wk low
64,00 €
EPS
3,29 €
Shares outstanding
18,00 млн
No. of employees
505
News stories
From web sources and news partners
About Pharma Mar SA
CEO-
Employees505
Founded1986
Headquarters-
Sector-
Websitepharmamar.com
Last report
2026-ж., 29-окт.
Fiscal period
Q3 2026
0,47 € / 0,00 €
+14 014,11%beat
Revenue / Est. (EUR)
0,00 / 50,68 млн
0,00%miss
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in EUR
Loading Previous Earnings...
Revenue
Net income
All values in EUR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
35,66 млн
90,48 млн
42,90 млн
49,60 млн
Cost of goods sold
2,30 млн
3,77 млн
3,66 млн
4,73 млн
Cost of revenue
2,30 млн
3,77 млн
3,66 млн
4,73 млн
Research and development expenses
22,13 млн
25,59 млн
20,88 млн
26,38 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6,63 млн
17,31 млн
15,31 млн
17,12 млн
Operating expense
37,32 млн
43,09 млн
38,62 млн
46,28 млн
Total operating expenses
39,62 млн
46,87 млн
42,28 млн
51,01 млн
Operating income
-3,96 млн
43,61 млн
622,00 миң
-1,40 млн
Other non operating income
-
-
-
-
EBT including unusual items
-4,08 млн
44,28 млн
1,60 млн
-993,00 миң
EBT excluding unusual items
-4,08 млн
44,28 млн
1,60 млн
-993,00 миң
Income tax expense
24,00 миң
-15,39 млн
65,00 миң
-21,00 миң
Effective tax rate
-0,59%
-34,75%
4,07%
2,11%
Other operating expenses
8,56 млн
195,00 миң
2,43 млн
2,77 млн
Net income
-4,10 млн
59,66 млн
1,53 млн
-972,00 миң
Net profit margin
-11,50%
65,95%
3,57%
-1,96%
Earnings per share
-
-
-
-
Interest and investment income
-
3,44 млн
976,00 миң
412,00 миң
Interest expense
-117,00 миң
-724,00 миң
-
-
Net interest expenses
-117,00 миң
2,72 млн
976,00 миң
412,00 миң
Depreciation and amortization charges
-
-
-
-
EBITDA
-1,95 млн
45,64 млн
2,71 млн
700,00 миң
Gain or loss from assets sale
-10,00 миң
-754,00 миң
-
-
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору